Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Sarcoma 1Neuroblastoma 1Brain Neoplasms 1

Interventions

Specimen Handling 10Biopsy 9Magnetic Resonance Spectroscopy 8pembrolizumab 6Cyclophosphamide 6X-Rays 5Phantoms, Imaging 5Doxorubicin 5Nuclear Medicine Department, Hospital 4liposomal doxorubicin 3fludarabine 3atezolizumab 3Radiation 3Irinotecan 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2larotrectinib 2ivosidenib 2fludarabine phosphate 2ensartinib 2anlotinib 2Temozolomide 2Surveys and Questionnaires 2Radiotherapy 2Ifosfamide 2Fluorodeoxyglucose F18 2Carboplatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma × Interleukin-15 × 30 days × Clear all
NCT01875601 2026-05-22

NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
16 enrolled
CNSSarcoma

Brain Neoplasms, Neuroblastoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡